Open Access 01-12-2016 | Commentary
Surrogate endpoints and competing risk of death in cardiac arrest research
Published in: Critical Care | Issue 1/2016
Login to get accessAbstract
We urgently need new therapies to improve outcomes after cardiac arrest. Initial studies typically target surrogate endpoints, and these studies help to inform subsequent larger trials that are powered to measure more patient-orientated clinical outcomes such as survival. The competing risk of death and premature assessment of neurological prognosis pose significant challenges to measuring these surrogate endpoints after cardiac arrest.